Transdermal solvent system and methods of use
AssigneeDonaghys Limited
InventorKAREN YERITSYAN
Life of this patent
Estimating the term…
Abstract
Described herein are transdermal solvent systems comprising at least one active agent in solution in a base solution, the base solution comprising at least one fatty acid ester compound, at least one monoterpene compound and a co-solvent in the form of DMSO or DMI and at least one plant oil. The base solution was found to be highly versatile and provide superior or at least comparable skin penetration efficacy and active agent compatibility. Methods of treatment, uses of the solvent system and methods of manufacture are also described.
Claims20
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A base solution formulated to carry, in solution, at least one active agent and to deliver the at least one active agent via transdermal administration, the base solution comprising:
- 10-20% by weight of at least one fatty acid ester compound;
- 1-14.99% by weight of at least one monoterpene compound;
- 8-25% by weight dimethylsulfoxide (DMSO) and/or dimethyl isosorbide (DMI);
- 0.75-5% by weight of at least one plant oil;
- 0.1-25% by weight of at least one amphiphilic compound;
- 5-20% by weight at least one compound with emollient and/or humectant properties;
- 5-10% by weight at least one compound that acts is a wetting agent and/or emulsifier;
- and
- at least one ethylene glycol ether compound as a diluent added to volume q.s.
Dependencies are inferred from the claim text.